Literature DB >> 22947527

Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage.

Fariborz Mansour-Ghanaei1, Mojtaba Mehrdad, Sahereh Mortazavi, Farahnaz Joukar, Mohammad Khak, Zahra Atrkar-Roushan.   

Abstract

OBJECTIVE: Thyroid hormones profile in patients with hepatic cirrhosis due to chronic HBV and HCV infections was evaluated in order to find any relationship between thyroid hormones and severity of liver damage.
MATERIAL AND METHODS: Patients with the diagnosis of hepatic cirrhosis due to hepatitis B or C were screened for thyroid function status. Child-Pugh and model for end-stage liver disease (MELD) scores were calculated. Considering each thyroid function test, patients were divided into two groups with lower than normal and normal range of thyroid hormones, separately for each (for TSH, normal and upper than nor- mal). The correlation between thyroid function tests and severity of liver disease was taken into account.
RESULTS: Number of patients with a T3 level lower than normal range (70-110 ng/dL) significantly increased along with Child-Pugh scores A, B and C. A negative correlation was found between Child-Pugh scores and total serum T3 level (r = -0.453, P < 0.001). Also a reverse correlation was observed between MELD score and T3 levels (r = -0.305, P = 0.14).
CONCLUSION: In conclusion serum T3 concentration is a good index of hepatic function, decreasing by the severity of liver damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22947527

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  10 in total

1.  Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.

Authors:  H-C Chi; S-L Chen; S-L Lin; C-Y Tsai; W-Y Chuang; Y-H Lin; Y-H Huang; M-M Tsai; C-T Yeh; K-H Lin
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  The Clinical Value of Thyroid Hormone Levels and Correlation with Severity of Liver Cirrhosis.

Authors:  Chang Liu; Li Li; Li Zeng
Journal:  Comput Intell Neurosci       Date:  2022-06-06

Review 3.  Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma.

Authors:  Po-Shuan Huang; Chia-Siu Wang; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

4.  The Pattern of Dyslipidemia in Chronic Liver Disease Patients.

Authors:  Umar Farooque; Ashok Kumar Lohano; Quratulain Dahri; Nazia Arain; Fnu Farukhuddin; Chinmay Khadke; Febin Prince; Rizwan Farooque; Mostafa A Shehata; Muhammad Daim Bin Zafar
Journal:  Cureus       Date:  2021-02-10

5.  Transcriptome Profile of Thyroid Glands in Bile Duct Ligation Mouse Model.

Authors:  Danbi Jo; Hee Kyung Kim; Young-Kook Kim; Juhyun Song
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 6.  Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.

Authors:  Hsiang Cheng Chi; Cheng-Yi Chen; Ming-Ming Tsai; Chung-Ying Tsai; Kwang-Huei Lin
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

7.  Introducing an optimal liver allocation system for liver cirrhosis patients.

Authors:  Jamileh Abolghasemi; Mohammad Reza Eshraghian; Mohsen Nasiri Toosi; Mahmood Mahmoodi; Abbas Rahimi Foroushani
Journal:  Hepat Mon       Date:  2013-08-30       Impact factor: 0.660

8.  The abnormality of thyroid hormones in patients with type A hepatic encephalopathy.

Authors:  Lin Wang; Wanyou Yu; Wukui Cao; Wei Lu
Journal:  Oncotarget       Date:  2017-06-29

9.  A Study of Thyroid Dysfunction in Cirrhosis of Liver and Correlation with Severity of Liver Disease.

Authors:  P Punekar; Ashvanee Kumar Sharma; A Jain
Journal:  Indian J Endocrinol Metab       Date:  2018 Sep-Oct

10.  Predictors of inflammatory activity in treatment-naive hepatitis B e-antigen-negative patients with chronic hepatitis B infection.

Authors:  Jianhua Hu; Yong Wang; Gongying Jiang; Jie Zheng; Tuxiang Chen; Zhiping Chen; Meifang Yang; Xuan Zhang; Hong Zhao; Lanjuan Li
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.